Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Total Liabilities: 2009-2024

Historic Total Liabilities for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Dec 2024 value amounting to $117.7 million.

  • Vanda Pharmaceuticals' Total Liabilities rose 30.08% to $135.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $135.1 million, marking a year-over-year increase of 30.08%. This contributed to the annual value of $117.7 million for FY2024, which is 13.65% up from last year.
  • According to the latest figures from FY2024, Vanda Pharmaceuticals' Total Liabilities is $117.7 million, which was up 13.65% from $103.5 million recorded in FY2023.
  • Over the past 5 years, Vanda Pharmaceuticals' Total Liabilities peaked at $117.7 million during FY2024, and registered a low of $80.2 million during FY2020.
  • Moreover, its 3-year median value for Total Liabilities was $107.0 million (2022), whereas its average is $109.4 million.
  • Per our database at Business Quant, Vanda Pharmaceuticals' Total Liabilities increased by 20.46% in 2022 and then dropped by 3.29% in 2023.
  • Over the past 5 years, Vanda Pharmaceuticals' Total Liabilities (Yearly) stood at $80.2 million in 2020, then increased by 10.82% to $88.9 million in 2021, then increased by 20.46% to $107.0 million in 2022, then fell by 3.29% to $103.5 million in 2023, then increased by 13.65% to $117.7 million in 2024.